EW vs WSBCO
Edwards Lifesciences Corp (EW) versus WesBanco, Inc. (WSBCO) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
WesBanco, Inc. (WSBCO) is a banks - regional company listed on NASDAQ.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
WSBCO does not have a complete income-statement cache yet.
EW currently screens at market cap $49.91B and trailing P/E 46.9. WSBCO currently screens at market cap $0.
Not investment advice. Open the EW and WSBCO stock pages for the full models.
Not investment advice.